We are live on ! Find out more
CAM

Cresset Asset Management Portfolio holdings

AUM $23.1B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
AUM
$7.43B
AUM Growth
+$373M
Cap. Flow
+$381M
Cap. Flow %
5.12%
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$20.2M
2
CLDX icon
Celldex Therapeutics
CLDX
+$15.3M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$9.52M
4
PLTR icon
Palantir
PLTR
+$4.79M
5
RTX icon
RTX Corp
RTX
+$4.74M

Sector Composition

Rank Sector Weight
1 Technology 39.28%
2 Consumer Discretionary 6.79%
3 Healthcare 3.4%
4 Financials 3.36%
5 Communication Services 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUYA
1051
Huya Inc
HUYA
$558M
$164K ﹤0.01%
19,662
+2,323
+13% +$26.8K
OSUR icon
1052
OraSure Technologies
OSUR
$279M
$155K ﹤0.01%
13,692
+2,848
+26% +$31.3K
SRSA
1053
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$147K ﹤0.01%
14,950
PBR icon
1054
Petrobras
PBR
$116B
$143K ﹤0.01%
+13,844
New +$147K
AEG icon
1055
Aegon
AEG
$14.1B
$141K ﹤0.01%
28,972
+7,945
+38% +$34.4K
CIG.C icon
1056
CEMIG Ordinary Shares
CIG.C
$8.95B
$131K ﹤0.01%
67,629
+1,895
+3% +$3.38K
BRG
1057
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$129K ﹤0.01%
10,000
-4,000
-29% -$46.4K
KGC icon
1058
Kinross Gold
KGC
$32.8B
$128K ﹤0.01%
23,962
+2,760
+13% +$16.5K
ASTR
1059
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$128K ﹤0.01%
+980
New +$150K
PHUN icon
1060
Phunware
PHUN
$43.6M
$122K ﹤0.01%
2,617
KYN icon
1061
Kayne Anderson Energy Infrastructure Fund
KYN
$2.4B
$120K ﹤0.01%
15,002
+2
+0% +$16
BSBR icon
1062
Santander
BSBR
$43.5B
$119K ﹤0.01%
19,024
GFI icon
1063
Gold Fields
GFI
$36.5B
$111K ﹤0.01%
13,664
+571
+4% +$5.11K
PTRA
1064
DELISTED
Proterra Inc. Common Stock
PTRA
$111K ﹤0.01%
+10,928
New +$123K
AQST icon
1065
Aquestive Therapeutics
AQST
$494M
$109K ﹤0.01%
25,000
BBD icon
1066
Banco Bradesco
BBD
$36.7B
$108K ﹤0.01%
30,833
+3,000
+11% +$12K
DIDI
1067
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$108K ﹤0.01%
+13,899
New +$131K
AROC icon
1068
Archrock
AROC
$5.8B
$107K ﹤0.01%
12,996
+626
+5% +$5.04K
FCEL icon
1069
FuelCell Energy
FCEL
$1.63B
$106K ﹤0.01%
526
+40
+8% +$7.95K
ASX icon
1070
ASE Group
ASX
$82.2B
$105K ﹤0.01%
12,811
-746
-6% -$6.48K
IVAN.U
1071
DELISTED
Ivanhoe Capital Acquisition Corp. Unit, each consisting of one Class A ordinary share and one-third
IVAN.U
$104K ﹤0.01%
10,000
INKAU
1072
DELISTED
KludeIn I Acquisition Corp. Unit
INKAU
$100K ﹤0.01%
10,000
VLDR
1073
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$99K ﹤0.01%
+16,650
New +$125K
INVZ icon
1074
Innoviz Technologies
INVZ
$112M
$96K ﹤0.01%
+16,633
New +$131K
MFGP
1075
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$93K ﹤0.01%
17,032
+576
+4% +$3.24K

Similar funds

Cresset Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.

  • Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
  • Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
  • Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
  • Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
  • Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
  • Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
  • Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.

Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.